- Home
- NEGG vs AMRN Comparison
NEGG vs AMRN Comparison
Compare NEGG & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- AMRN
- Stock Information
- Founded
- NEGG 2001
- AMRN 1989
- Country
- NEGG United States
- AMRN Ireland
- Employees
- NEGG 932
- AMRN N/A
- Industry
- NEGG Other Specialty Stores
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- AMRN Health Care
- Exchange
- NEGG Nasdaq
- AMRN Nasdaq
- Market Cap
- NEGG 171.3M
- AMRN 189.2M
- IPO Year
- NEGG 2010
- AMRN 1993
- Fundamental
- Price
- NEGG $0.44
- AMRN $0.55
- Analyst Decision
- NEGG
- AMRN Buy
- Analyst Count
- NEGG 0
- AMRN 1
- Target Price
- NEGG N/A
- AMRN N/A
- AVG Volume (30 Days)
- NEGG 1.1M
- AMRN 1.1M
- Earning Date
- NEGG 08-29-2024
- AMRN 02-27-2025
- Dividend Yield
- NEGG N/A
- AMRN N/A
- EPS Growth
- NEGG N/A
- AMRN N/A
- EPS
- NEGG N/A
- AMRN N/A
- Revenue
- NEGG $1,391,833,000.00
- AMRN $241,021,000.00
- Revenue This Year
- NEGG $6.01
- AMRN N/A
- Revenue Next Year
- NEGG N/A
- AMRN N/A
- P/E Ratio
- NEGG N/A
- AMRN N/A
- Revenue Growth
- NEGG N/A
- AMRN N/A
- 52 Week Low
- NEGG $0.39
- AMRN $0.43
- 52 Week High
- NEGG $1.32
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- NEGG 43.37
- AMRN 50.48
- Support Level
- NEGG $0.39
- AMRN $0.55
- Resistance Level
- NEGG $0.49
- AMRN $0.61
- Average True Range (ATR)
- NEGG 0.04
- AMRN 0.04
- MACD
- NEGG 0.00
- AMRN -0.00
- Stochastic Oscillator
- NEGG 26.45
- AMRN 26.56
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.